Nuveen Asset Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $975K | Sell |
158,004
-54,550
| -26% | -$337K | ﹤0.01% | 2724 |
|
|
2024
Q3 | $1.14M | Hold |
212,554
| – | – | ﹤0.01% | 2697 |
|
|
2024
Q2 | $712K | Buy |
212,554
+54,550
| +35% | +$183K | ﹤0.01% | 2863 |
|
|
2024
Q1 | $637K | Hold |
158,004
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q4 | $419K | Buy |
158,004
+4,617
| +3% | +$12.2K | ﹤0.01% | 3063 |
|
|
2023
Q3 | $362K | Sell |
153,387
-1,152
| -0.7% | -$2.72K | ﹤0.01% | 2932 |
|
|
2023
Q2 | $974K | Buy |
154,539
+38,739
| +33% | +$244K | ﹤0.01% | 2665 |
|
|
2023
Q1 | $668K | Buy |
115,800
+21,728
| +23% | +$125K | ﹤0.01% | 2737 |
|
|
2022
Q4 | $965K | Sell |
94,072
-16,062
| -15% | -$165K | ﹤0.01% | 2694 |
|
|
2022
Q3 | $1.84M | Sell |
110,134
-1,327
| -1% | -$22.2K | ﹤0.01% | 2439 |
|
|
2022
Q2 | $1.56M | Buy |
111,461
+32,383
| +41% | +$453K | ﹤0.01% | 2566 |
|
|
2022
Q1 | $1.47M | Buy |
79,078
+5,965
| +8% | +$111K | ﹤0.01% | 2657 |
|
|
2021
Q4 | $1.32M | Buy |
73,113
+30,068
| +70% | +$542K | ﹤0.01% | 2750 |
|
|
2021
Q3 | $696K | Sell |
43,045
-468
| -1% | -$7.57K | ﹤0.01% | 3104 |
|
|
2021
Q2 | $865K | Buy |
+43,513
| New | +$865K | ﹤0.01% | 3055 |
|